AMOREPACIFIC (002790) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
21 May, 2026Executive summary
Revenue decreased 2.4% year-over-year to 1.01 trillion KRW, while operating profit rose 4.2% to 12.2 billion KRW, and net profit surged 1717.3% to 537.3 billion KRW, driven by non-recurring items.
Major subsidiary Amorepacific saw revenue fall 4.3% and operating profit drop 29.5% year-over-year.
COSRX's two-month earnings were consolidated, contributing to overall group results.
Financial highlights
Group revenue: 1.01 trillion KRW (-2.4% YoY); operating profit: 12.2 billion KRW (+4.2% YoY); net profit: 537.3 billion KRW (+1717.3% YoY).
Amorepacific revenue: 904.8 billion KRW (-4.3% YoY); operating profit: 4.2 billion KRW (-29.5% YoY).
Major subsidiaries: Innisfree revenue -13.4%, Etude -10.3%, Espoir +15.3%, Amos Professional +6.8%, Osulloc +11.8%.
Operating profit of major subsidiaries up 52% to 7.7 billion KRW; Innisfree turned to profit.
Outlook and guidance
Overseas business expected to benefit from COSRX consolidation and strong growth in Western regions.
Domestic business faces challenges from declining travel retail and new commerce channels.
Latest events from AMOREPACIFIC
- Strong overseas growth and COSRX drove double-digit revenue and profit gains despite China weakness.002790
Q3 202421 May 2026 - Revenue and operating profit rose, but net income fell amid higher costs and China weakness.002790
Q1 202629 Apr 2026 - Revenue and operating profit surged, led by global expansion and premiumization.002790
Q4 20256 Feb 2026 - Revenue and profit surged on strong brand performance and improved margins.002790
Q3 20259 Nov 2025 - Operating profit soared over 500% year-over-year, but net profit dropped on non-operating losses.002790
Q2 20251 Aug 2025 - Strong overseas and luxury segment growth fueled double-digit profit gains.002790
Q1 20256 Jun 2025 - Profit and revenue soared on overseas strength, offsetting domestic and China headwinds.002790
Q4 20245 Jun 2025